USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug
Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Adar Poonawalla-backed pharmacy chain Wellness Forever files for IPO
Apollo's digital platform move may fuel consolidation, benefit consumers
S&P upgrades Tata Steel, Tata Motors, JLR ratings over Tata Sons' influence
IDfy raises Rs 86 cr in series D funding led by TransUnion, Blume Ventures
Supreme Court rejects bail plea of ex-Amrapali director on medical grounds
Reliance Naval and Engineering lenders ask bidders to sweeten offers
Nirav Modi UK extradition appeal to be heard on December 14
 "Biocon")
